LOADING
Comparing Merck & Company (MRK) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $354.8B | $194.5B |
| P/E Ratio | 116.0 | 20.8 |
| Forward P/E | 15.3 | 19.6 |
| PEG Ratio | 2.71 | 0.88 |
| EPS | $1.24 | $8.74 |
| Revenue Growth (YoY) | 5.1% | -4.0% |
| Profit Margin | 4.8% | 21.0% |
| Return on Equity | 7.0% | 33.8% |
| Dividend Yield | 2.28% | 1.95% |
| Beta | 0.23 | 1.68 |
| 52-Week High | $156.00 | $257.56 |
| 52-Week Low | $79.67 | $120.88 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Qualcomm Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Qualcomm Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.